步长稳心颗粒治疗功能性早搏60例疗效分析

Effects of Buchang Wenxin Capsule in the Treatment of Functional Premature Beat

目的:观察步长稳心颗粒(简称稳心颗粒)治疗功能性早搏的临床疗效及安全性。方法:选择功能性早搏60例病人,随机分为治疗组及对照组,每组各30例。治疗组给予稳心颗粒一包(9克),每日三次,温开水冲服;对照组给予倍他乐克25毫克,每日二次口服,一个月为一疗程。结果:四周后治疗组显效11例,有效16例,总有效率90%。对照组显效8例,有效18例,总有效率86.7%,p>0.05,两组比较无显著性差异。对血压、心率影响方面稳心颗粒明显优于倍他乐克结论:稳心颗粒治疗功能性早搏疗效显著,且效果稳定,安全无明显不良反应,值得临床推广应用。

Objective： To investigatc the therapeutic effects and safety of Bucbang Wenxin capsule in the treatment of functional premature beat （FPB）. Methods： 60 patients with FPB were randomly divided into two groups： treatment group（n= 30） were given Buchang Wenxin capsule（9g） times a day and control group were given metoprolol（25mg） twice a day orally, respectively. A course of treatment was four weeks. Results. After four weeks, the toal effective rate was 90% in treatment group with the 11 noticeable and 16 effective; while that in control group was 86.7%, with the 8 noticeable and 18 effective（P〉 0.05）. There was no significant difference between the two groups. Conduston： In this study,Buchang Wenxin capsuh was superior to metoprolol, so it could be taken as an effective and safe medicine for treatment of FPB and well worth spreading in the clinical application.